Glimepiride Tablet
Product Images NDC 51655-489

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 51655-489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 489 52)

Glimepiride Tablets, USP 4 mg bottle label with 30 tablets, for oral use. The label includes storage instructions at controlled room temperature (68°-77°F), prescription status, and manufacturer information for Northwind Health Company, LLC. It lists package details, quantities, and various lot and serial numbers.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of glimepiride, showing its molecular framework including various ring systems and functional groups as typically depicted for this oral antidiabetic agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.